Infectious Disease Control Articles & Analysis
11 news found
SpyBiotech announces the appointments of Dan Menichella as Non-Executive Director and Dr Norman Begg as Scientific Advisor Oxford, U.K., March 8, 2021: SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases, today announces the appointments of Dan Menichella ...
CARB-X is awarding Vaxdyn, based in Seville, Spain, up to US$892,000, plus an additional $6.36 million if certain project milestones are met, to develop a new vaccine to prevent life-threatening drug-resistant infections, including pneumonia. Vaxdyn is the first Spanish biotech to be funded by CARB-X, a non-profit partnership investing $500 million in the development of innovative vaccines, ...
Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II. ...
Diagnostic advances play critical roles in controlling infectious disease outbreaks, supporting prevention efforts, and improving patient treatment outcomes. ...
Symptoms of pertussis usually develop within 7–10 days after being exposed, but sometimes it may take as long as 6 weeks. One Illinois infection control company that has been on the forefront of helping schools, hospitals and institutions battle infectious diseases is EC2, Inc. “An infected person can be contagious from just ...
Acinetobacter can cause a variety of diseases, ranging from pneumonia to serious blood or wound infections, and the symptoms vary depending on the disease. ...
Scientists from the University of Maryland’s School of Medicine recently conducted research into the presence of multi-drug resistant Acinetobacter baumannii (MDR-AB) in patient rooms in medical facilities. The research was published in the American Journal of Infection Control (AJIC). Researchers found that MDR-AB was present in the environment of 48% of the rooms of patients infected ...
Cryptococcosis is a potentially deadly disease caused by Cryptococcus fungi. The major species of Cryptococcus that causes illness in humans is Cryptococcus neoformans, which is found worldwide. Since 1999, C. gattii, which can also cause infections, has also been found in regions of the Pacific Northwest. C. neoformans typically infects immune-compromised persons. Most people in the United ...
These infections can be caused by a wide range of bacteria, fungi and viruses. According to the Centers for Disease Control and Prevention (CDC), “Approximately 1 out of every 20 hospitalized patients will contract an HAI.” “Infection control procedures are a critical part of the healthcare system,” reported Ed ...
(OTCBB:TOMZ), a global green leader in infectious disease control and surface and air remediation, announced today that it made its first sale to a developer in Abu Dhabi, United Arab Emirates. ...
Our goal is to increase awareness about risk exposures for patients and workers to emerging infectious diseases during healthcare construction. RAP provides tools for reducing risk and managing liability for the healthcare industry. The training courses would benefit Risk Directors, Facility Directors, Property Managers, Architects, Engineers, Environmental ...
ByEurofins